Sort
51,570 grants matching “autoimmune disease”
Rare Variants and Risk of Type 1 Diabetes
$474,526Stephen S. Rich · University Of Virginia · R01 · FY2012 · DK
Undergraduate Research for Dose-Controllable Drug Delivery Implants
$474,519Yoonjee Park · University Of Cincinnati · R15 · FY2021 · EY
HVEM-BTLA system in inflammation
$474,500Carl F Ware · La Jolla Institute For Immunology · R01 · FY2007 · AI
Air Pollution and Pregnancy Loss
$474,451Maya Ariane Deyssenroth · Columbia University Health Sciences · R01 · FY2024 · ES
Novel roles for the DNA damage response kinase CHK1 in TCR/ITAM signaling
$474,449Carrie L. Lucas · Yale University · R01 · FY2018 · AI
Intrinsic B cell epigenetic regulation of antibody and autoantibody responses by Sirt1
$474,357Paolo Casali · University Of Texas Hlth Science Center · R01 · FY2020 · AI
Intrinsic B cell epigenetic regulation of antibody and autoantibody responses by Sirt1
$474,357Paolo Casali · University Of Texas Hlth Science Center · R01 · FY2021 · AI
Intrinsic B cell epigenetic regulation of antibody and autoantibody responses by Sirt1
$474,356Paolo Casali · University Of Texas Hlth Science Center · R01 · FY2022 · AI
Intrinsic B cell epigenetic regulation of antibody and autoantibody responses by Sirt1
$474,356Paolo Casali · University Of Texas Hlth Science Center · R01 · FY2023 · AI
Prothrombin Gene Variation and the Risk of SLE and CHD
$474,249M. Ilyas Kamboh · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · HL
Resource for Nonhuman Primate Immune Reagents
$474,190Francois J Villinger · Emory University · R24 · FY2013 · OD
How Proinflammatory Cytokines Block T Cell Death In Vivo
$474,165Anthony T. Vella · University Of Connecticut Sch Of Med/Dnt · R01 · FY2015 · AI
Regulatory immune cells in immune suppression: The role of tBregs
$474,095Bira Arya · National Institute On Aging · ZIA · FY2015 · AG
Mechanism of Lacrimal Gland Secretion
$474,076Darlene A Dartt · Schepens Eye Research Institute · R01 · FY2008 · EY
AHR-mediated immunosuppression in glioblastoma
$474,075Francisco J. Quintana · Brigham And Women'S Hospital · R01 · FY2022 · ES
Lupus Glomenulonephritis and NK T cells
$474,044Samuel Strober · Stanford University · R01 · FY2009 · DK
Immunomodulation targeting abnormal conformation and the influence of apoE
$474,020Fernando Goni · New York University School Of Medicine · P01 · FY2023 · AG
Immunomodulation targeting abnormal conformation and the influence of apoE
$474,020Fernando Goni · New York University School Of Medicine · P01 · FY2021 · AG
Mapping the T cell receptor/antigen complex and identifying the genetic-based treatment in Sjogrenâs syndrome
$474,011Cuong Q Nguyen · University Of Florida · R01 · FY2022 · DE
Self Peptides Bound to MHC Class II In T Cell Selection
$474,000Alexander Y. Rudensky · Sloan-Kettering Inst Can Research · R37 · FY2009 · AI
MICROBIOTA SPECIFIC T CELL SELECTION
$474,000Matthew Bettini · Baylor College Of Medicine · R01 · FY2019 · AI
Development Of Drugs Acting At Adenosine Receptors
$473,998Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK
TAM Receptor Regulation of Innate Immunity
$473,963Greg E Lemke · Salk Institute For Biological Studies · R01 · FY2010 · AI
Study of FcR Genes: Macrophages and Lymphocytes
$473,960Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2009 · AI
Engineering an extracellular vesicle-based targeted regenerative nanotherapeutic for multiple sclerosis
$473,938Aijun Wang · University Of California At Davis · R01 · FY2025 · NS